Market Place
Sourcing Support
Novo’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
13 Mar 2026 //
BIOSPACE
Novo Holdings Announces 2025 Annual Results
12 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk receives FDA warning linked to US inspection in 2025
11 Mar 2026 //
REUTERS
FDA Issues Form 483 to Novo Nordisk
10 Mar 2026 //
FDA
Novo Nordisk’s Receives FDA Warning Letter
10 Mar 2026 //
FDA
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
Novo Nordisk Launches Share Repurchase Program
09 Mar 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk Again For Misleading GLP-1 AD
05 Mar 2026 //
RAPS
Novo Earns FDA Untitled Letter For Apple-Inspired Ozempic Ad
04 Mar 2026 //
FIERCE PHARMA
Keytruda Hangs On To Best Seller Crown As Glp-1s Gain Ground
04 Mar 2026 //
BIOSPACE
Novo Charts $500M Ireland Upgrade To Produce Wegovy Pill
03 Mar 2026 //
FIERCE PHARMA
Novo Nordisk A/S: Share Repurchase Programme
02 Mar 2026 //
GLOBENEWSWIRE
Novo Nordisk Elects Employee Representatives To Board
02 Mar 2026 //
GLOBENEWSWIRE
Abbott Signs Pact With Novo Nordisk To Offer Semaglutide
28 Feb 2026 //
ECONOMICTIMES
FDA approves Novo`s Sogroya as the first and only FDA Approval
28 Feb 2026 //
PR NEWSWIRE
Novo, Vivtex in up to US$2.1 bn Obesity Deal
27 Feb 2026 //
GLOBENEWSWIRE
Lilly Tops Novo In Weight Loss Again, This Time On The Oral Front
26 Feb 2026 //
BIOSPACE
Novo`s UBT251 Hits 19.7% Weight Loss in China Phase 2 Trial
25 Feb 2026 //
GLOBENEWSWIRE
Novo Plans List Price Reduction For Semaglutide Drugs In `27
24 Feb 2026 //
FIERCE PHARMA
Novo`s CagriSema Trial Deals Blow in Obesity drug Battle Lilly
24 Feb 2026 //
REUTERS
Novo Nordisk A/S: Share Repurchase Programme
23 Feb 2026 //
GLOBENEWSWIRE
Madrigal Embraces Novo Competition As MASH Drug Gains Steam
19 Feb 2026 //
FIERCE PHARMA
Madrigal embraces Novo Competition as MASH Drug Gains Steam
18 Feb 2026 //
FIERCE PHARMA
Dr Reddy`s Readies Day-1 Launch Of Semaglutide Generic
18 Feb 2026 //
ECONOMICTIMES
EU Approves Enhanced Wegovy for Obesity in Adults
17 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - Share Repurchase Programme
16 Feb 2026 //
GLOBENEWSWIRE
Oral Wegovy Brings In Thousands Of New GLP-1 Patients
12 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
11 Feb 2026 //
GLOBENEWSWIRE
Novo, Lilly Earnings Ignite Weight Loss Drama, Gene Therapy Buzz
11 Feb 2026 //
BIOSPACE
Novo Nordisk Board Members And Executives Trade Company Shares
10 Feb 2026 //
GLOBENEWSWIRE
FDA Cites Novo Nordisk For Airing Misleading Wegovy Ad
10 Feb 2026 //
RAPS
FDA Untitled Letters Target Drug Ads From Novo, Argenx, Sobi
10 Feb 2026 //
FIERCE PHARMA
Hims & Hers’ Woes Compound as FDA Hit Company With Warning Letter
10 Feb 2026 //
BIOSPACE
Novo Nordisk Sues Hims & Hers Over Counterfeit Wegovy®
09 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk A/S - Share Repurchase Programme
09 Feb 2026 //
GLOBENEWSWIRE
Hims Quits On Obesity Pill After Legal, Regulatory Heat
09 Feb 2026 //
FIERCE PHARMA
Makary Criticizes `Illegal Copycat Drugs` Amid Hims` Compounded
06 Feb 2026 //
BIOSPACE
Amylin`s Oral Obesity Assets Gain Momentum In 2026
06 Feb 2026 //
BIOSPACE
The Biggest Potential Drug Launches Of 2026
06 Feb 2026 //
FIERCE PHARMA
Novo`s 1St Super Bowl Ad Taps Celebs To Tout Wegovy Pill
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Launches Wegovy® Pill For Consumers At Major Event
06 Feb 2026 //
PR NEWSWIRE
US Government Launches Trumprx Drug Purchasing Portal
06 Feb 2026 //
FIERCE PHARMA
FDA Commissioner Pledges Crackdown On Compounding Practices
06 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Fires Back at Hims` $49 Semaglutide Pill
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Flags Concerns Over Pharmazee GLP-1 Scripts
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Board, Executives, and Associates Trade Shares
05 Feb 2026 //
GLOBENEWSWIRE
Hims & Hers Plans To Launch $49 Copy Of Wegovy Pill
05 Feb 2026 //
FIERCE PHARMA
Novo Nordisk Addresses Hims & Hers` Illegal Compounding
05 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Files Annual Report With The SEC
04 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk`s Sales Rise 10% To DKK 309.1B In 2025
03 Feb 2026 //
GLOBENEWSWIRE
Novo Nordisk Releases 2026 Sales And Operating Profit Outlook
03 Feb 2026 //
GLOBENEWSWIRE
Novo Slides 14% On Early Q4 Results Forecasting 2026 Sales Drop
03 Feb 2026 //
BIOSPACE
Novo`s next-gen obesity drug outperforms Wegovy in diabetes trial
02 Feb 2026 //
REUTERS
Obesity Market Sales Tightens as Novo & Lilly Enter New Era
02 Feb 2026 //
REUTERS
Novo`s Cagrisema Tops Semaglutide In Ph. 3 Diabetes Study
02 Feb 2026 //
FIERCE BIOTECH
Novo Nordisk A/S Appoints New Board Member
31 Jan 2026 //
GLOBENEWSWIRE
Betterway Introduces GLP-1 Blood Test Panel At Austin, Temple
29 Jan 2026 //
PHARMIWEB
Novo Wins Support From Big Business In Its Ongoing IRA Challenge
29 Jan 2026 //
FIERCE PHARMA
Roche Plans To Go Toe-To-Toe With Novo, Lilly In Obesity
29 Jan 2026 //
BIOSPACE
With 200 JPM Meetings, Novo BD Head Seeks Out The Next Metsera
27 Jan 2026 //
FIERCE BIOTECH
